1. Will other drugmakers end up with deals like Endo’s $10M opioid settlement? — AstraZeneca Imfinzi combo fails advanced lung cancer study — FDA says they were “lucky” with Novartis data manipulation controversy — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. What happened a year ago this week in biopharma? Regeneron’s Eylea approval, Novartis’ new ethics czar, Vertex’s Kalydeco, and Opidvo’s SCLC approval click to review and read a current update of the big stories from one year ago
    Dismiss Notice

How do I...

Do you have questions on how to use the message boards? Want to know how to post, how to insert links, post polls, change your user options, etc.? Simply post your question here and we will answer as soon as possible.

Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    0
    Views:
    851
  2. BlueDevil11
    Replies:
    0
    Views:
    570
  3. JoshSackman
    Replies:
    1
    Views:
    637
  4. DALLAS7
    Replies:
    0
    Views:
    1,081
  5. Keister
    Replies:
    0
    Views:
    811
  6. anonymous
    Replies:
    1
    Views:
    1,073
  7. Sarah Joel
    Replies:
    0
    Views:
    1,782
  8. DouglasF
    Replies:
    0
    Views:
    1,497
  9. PharmaGalWPB85
    Replies:
    0
    Views:
    1,605
  10. EmployeeforLife
    Replies:
    0
    Views:
    1,069
  11. Huskerlover
    Replies:
    0
    Views:
    1,272
  12. Huskerlover
    Replies:
    0
    Views:
    1,400
  13. Anonymous
    Replies:
    9
    Views:
    14,181
  14. anonymous
    Replies:
    0
    Views:
    1,122
  15. scientist
    Replies:
    1
    Views:
    2,909
  16. Terry2
    Replies:
    3
    Views:
    1,341
  17. anonymous
    Replies:
    0
    Views:
    1,112
  18. Rob P.
    Replies:
    0
    Views:
    1,263
  19. Anonymous
    Replies:
    2
    Views:
    6,801
  20. Alina Silviu
    Replies:
    0
    Views:
    1,181

Thread Display Options

Loading...